<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cyclopharm Ltd — News on 6ix</title>
    <link>https://6ix.com/company/cyclopharm-ltd</link>
    <description>Latest news and press releases for Cyclopharm Ltd on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 31 Mar 2026 02:03:04 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/cyclopharm-ltd" rel="self" type="application/rss+xml" />
    <item>
      <title>USA Technegas Expansion Update</title>
      <link>https://6ix.com/company/cyclopharm-ltd/news/usa-technegas-expansion-update</link>
      <guid isPermaLink="true">https://6ix.com/company/cyclopharm-ltd/news/usa-technegas-expansion-update</guid>
      <pubDate>Tue, 31 Mar 2026 02:03:04 GMT</pubDate>
      <description>USA Technegas Expansion Update</description>
    </item>
    <item>
      <title>CYC Secures Multi-Site Agreement with Northwestern Medicine</title>
      <link>https://6ix.com/company/cyclopharm-ltd/news/cyc-secures-multi-site-agreement-with-northwestern-medicine</link>
      <guid isPermaLink="true">https://6ix.com/company/cyclopharm-ltd/news/cyc-secures-multi-site-agreement-with-northwestern-medicine</guid>
      <pubDate>Tue, 24 Mar 2026 01:49:04 GMT</pubDate>
      <description>CYC Secures Multi-Site Agreement with Northwestern Medicine</description>
    </item>
    <item>
      <title>CYC Signs Enterprise Agreement with UPHS</title>
      <link>https://6ix.com/company/cyclopharm-ltd/news/cyc-signs-enterprise-agreement-with-uphs</link>
      <guid isPermaLink="true">https://6ix.com/company/cyclopharm-ltd/news/cyc-signs-enterprise-agreement-with-uphs</guid>
      <pubDate>Mon, 23 Mar 2026 02:37:05 GMT</pubDate>
      <description>CYC Signs Enterprise Agreement with UPHS</description>
    </item>
    <item>
      <title>Preliminary Final Report</title>
      <link>https://6ix.com/company/cyclopharm-ltd/news/preliminary-final-report-179</link>
      <guid isPermaLink="true">https://6ix.com/company/cyclopharm-ltd/news/preliminary-final-report-179</guid>
      <pubDate>Wed, 25 Feb 2026 11:33:03 GMT</pubDate>
      <description>Preliminary Final Report</description>
    </item>
    <item>
      <title>Technegas US Footprint Expanding Across Four Regions</title>
      <link>https://6ix.com/company/cyclopharm-ltd/news/technegas-us-footprint-expanding-across-four-regions</link>
      <guid isPermaLink="true">https://6ix.com/company/cyclopharm-ltd/news/technegas-us-footprint-expanding-across-four-regions</guid>
      <pubDate>Thu, 19 Feb 2026 06:52:02 GMT</pubDate>
      <description>Technegas US Footprint Expanding Across Four Regions</description>
    </item>
    <item>
      <title>Technegas Approved at the US National Institutes of Health</title>
      <link>https://6ix.com/company/cyclopharm-ltd/news/technegas-approved-at-the-us-national-institutes-of-health</link>
      <guid isPermaLink="true">https://6ix.com/company/cyclopharm-ltd/news/technegas-approved-at-the-us-national-institutes-of-health</guid>
      <pubDate>Wed, 18 Feb 2026 06:53:03 GMT</pubDate>
      <description>Technegas Approved at the US National Institutes of Health</description>
    </item>
    <item>
      <title>Cyclopharm Capital Raising Investor Presentation</title>
      <link>https://6ix.com/company/cyclopharm-ltd/news/cyclopharm-capital-raising-investor-presentation</link>
      <guid isPermaLink="true">https://6ix.com/company/cyclopharm-ltd/news/cyclopharm-capital-raising-investor-presentation</guid>
      <pubDate>Wed, 04 Feb 2026 04:02:05 GMT</pubDate>
      <description>Cyclopharm Capital Raising Investor Presentation</description>
    </item>
    <item>
      <title>Cyclopharm Successfully Completes A$14 million Placement</title>
      <link>https://6ix.com/company/cyclopharm-ltd/news/cyclopharm-successfully-completes-adollar14-million-placement</link>
      <guid isPermaLink="true">https://6ix.com/company/cyclopharm-ltd/news/cyclopharm-successfully-completes-adollar14-million-placement</guid>
      <pubDate>Wed, 04 Feb 2026 04:01:06 GMT</pubDate>
      <description>Cyclopharm Successfully Completes A$14 million Placement</description>
    </item>
    <item>
      <title>CYC Unaudited Trading Update - Preliminary FY2025 Results</title>
      <link>https://6ix.com/company/cyclopharm-ltd/news/cyc-unaudited-trading-update-preliminary-fy2025-results</link>
      <guid isPermaLink="true">https://6ix.com/company/cyclopharm-ltd/news/cyc-unaudited-trading-update-preliminary-fy2025-results</guid>
      <pubDate>Mon, 02 Feb 2026 04:00:07 GMT</pubDate>
      <description>CYC Unaudited Trading Update - Preliminary FY2025 Results</description>
    </item>
    <item>
      <title>Trading Halt</title>
      <link>https://6ix.com/company/cyclopharm-ltd/news/trading-halt-582</link>
      <guid isPermaLink="true">https://6ix.com/company/cyclopharm-ltd/news/trading-halt-582</guid>
      <pubDate>Mon, 02 Feb 2026 03:28:06 GMT</pubDate>
      <description>Trading Halt</description>
    </item>
    <item>
      <title>COPD Study Leveraging Technegas and AI-Driven Lung Analysis</title>
      <link>https://6ix.com/company/cyclopharm-ltd/news/copd-study-leveraging-technegas-and-ai-driven-lung-analysis</link>
      <guid isPermaLink="true">https://6ix.com/company/cyclopharm-ltd/news/copd-study-leveraging-technegas-and-ai-driven-lung-analysis</guid>
      <pubDate>Thu, 29 Jan 2026 02:40:09 GMT</pubDate>
      <description>COPD Study Leveraging Technegas and AI-Driven Lung Analysis</description>
    </item>
    <item>
      <title>Technegas Recognised in Updated Clinical Guideline</title>
      <link>https://6ix.com/company/cyclopharm-ltd/news/technegas-recognised-in-updated-clinical-guideline</link>
      <guid isPermaLink="true">https://6ix.com/company/cyclopharm-ltd/news/technegas-recognised-in-updated-clinical-guideline</guid>
      <pubDate>Tue, 27 Jan 2026 03:21:06 GMT</pubDate>
      <description>Technegas Recognised in Updated Clinical Guideline</description>
    </item>
    <item>
      <title>Insurer Indemnifies Cyclopharm</title>
      <link>https://6ix.com/company/cyclopharm-ltd/news/insurer-indemnifies-cyclopharm</link>
      <guid isPermaLink="true">https://6ix.com/company/cyclopharm-ltd/news/insurer-indemnifies-cyclopharm</guid>
      <pubDate>Tue, 27 Jan 2026 02:48:18 GMT</pubDate>
      <description>Insurer Indemnifies Cyclopharm</description>
    </item>
    <item>
      <title>Stanford Children&apos;s Health to Implement Technegas</title>
      <link>https://6ix.com/company/cyclopharm-ltd/news/stanford-childrens-health-to-implement-technegas</link>
      <guid isPermaLink="true">https://6ix.com/company/cyclopharm-ltd/news/stanford-childrens-health-to-implement-technegas</guid>
      <pubDate>Mon, 12 Jan 2026 02:49:14 GMT</pubDate>
      <description>Stanford Children&apos;s Health to Implement Technegas</description>
    </item>
    <item>
      <title>Colombia Approval Marks 67th Country for Technegas</title>
      <link>https://6ix.com/company/cyclopharm-ltd/news/colombia-approval-marks-67th-country-for-technegas</link>
      <guid isPermaLink="true">https://6ix.com/company/cyclopharm-ltd/news/colombia-approval-marks-67th-country-for-technegas</guid>
      <pubDate>Mon, 22 Dec 2025 03:45:09 GMT</pubDate>
      <description>Colombia Approval Marks 67th Country for Technegas</description>
    </item>
    <item>
      <title>Cyclopharm Bell Potter Healthcare Conference Presentation</title>
      <link>https://6ix.com/company/cyclopharm-ltd/news/cyclopharm-bell-potter-healthcare-conference-presentation</link>
      <guid isPermaLink="true">https://6ix.com/company/cyclopharm-ltd/news/cyclopharm-bell-potter-healthcare-conference-presentation</guid>
      <pubDate>Wed, 19 Nov 2025 02:51:07 GMT</pubDate>
      <description>Cyclopharm Bell Potter Healthcare Conference Presentation</description>
    </item>
    <item>
      <title>Legal Proceedings</title>
      <link>https://6ix.com/company/cyclopharm-ltd/news/legal-proceedings-2</link>
      <guid isPermaLink="true">https://6ix.com/company/cyclopharm-ltd/news/legal-proceedings-2</guid>
      <pubDate>Tue, 07 Oct 2025 12:10:08 GMT</pubDate>
      <description>Legal Proceedings</description>
    </item>
    <item>
      <title>S&amp;P DJI Announces September 2025 Quarterly Rebalance</title>
      <link>https://6ix.com/company/cyclopharm-ltd/news/sandp-dji-announces-september-2025-quarterly-rebalance-87</link>
      <guid isPermaLink="true">https://6ix.com/company/cyclopharm-ltd/news/sandp-dji-announces-september-2025-quarterly-rebalance-87</guid>
      <pubDate>Fri, 05 Sep 2025 11:28:14 GMT</pubDate>
      <description>S&amp;P DJI Announces September 2025 Quarterly Rebalance</description>
    </item>
    <item>
      <title>CYC 1H2025 Results Summary</title>
      <link>https://6ix.com/company/cyclopharm-ltd/news/cyc-1h2025-results-summary</link>
      <guid isPermaLink="true">https://6ix.com/company/cyclopharm-ltd/news/cyc-1h2025-results-summary</guid>
      <pubDate>Wed, 27 Aug 2025 11:26:06 GMT</pubDate>
      <description>CYC 1H2025 Results Summary</description>
    </item>
    <item>
      <title>Half Yearly Report and Accounts</title>
      <link>https://6ix.com/company/cyclopharm-ltd/news/half-yearly-report-and-accounts-259</link>
      <guid isPermaLink="true">https://6ix.com/company/cyclopharm-ltd/news/half-yearly-report-and-accounts-259</guid>
      <pubDate>Wed, 27 Aug 2025 11:10:13 GMT</pubDate>
      <description>Half Yearly Report and Accounts</description>
    </item>
  </channel>
</rss>